Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV and malignancy

M J Boyle1, W A Sewell, S T Milliken

  • 1Centre for Immunology, University of New South Wales, Sydney, Australia.

Journal of Acquired Immune Deficiency Syndromes
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells.

Breast cancer research : BCR·2025
Same author

Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer Cells.

Research square·2024
Same author

Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer Cells.

bioRxiv : the preprint server for biology·2024
Same author

IgM in human immunity to <i>Plasmodium falciparum</i> malaria.

Science advances·2019
Same author

The effect of antibiotic timing on culture yield in paediatric osteoarticular infection.

Journal of children's orthopaedics·2019
Same author

Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study.

HIV medicine·2018
Same journal

T lymphocyte homeostasis after HIV seroconversion.

Journal of acquired immune deficiency syndromes·1994
Same journal

Improved detection of HTLV-II antibody using a whole viral lysate-based EIA.

Journal of acquired immune deficiency syndromes·1994
Same journal

Changes in HIV risk behavior among French heterosexuals: patterns of sexual monogamy and condom use between 1988 and 1991.

Journal of acquired immune deficiency syndromes·1994
Same journal

HTLV-I-associated myelopathy in Venezuela.

Journal of acquired immune deficiency syndromes·1994
Same journal

Autoantibodies to nucleosomes in HIV-1-infected patients.

Journal of acquired immune deficiency syndromes·1994
Same journal

Seroprevalence of HIV-1 and syphilis antibodies in blood donors in Gonder, Ethiopia, 1989-1993.

Journal of acquired immune deficiency syndromes·1994
See all related articles

Research into cancers in people with human immunodeficiency virus (HIV) focuses on Kaposi

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Background:

  • Human immunodeficiency virus (HIV) infection is associated with an increased risk of certain malignancies.
  • Kaposi's sarcoma and non-Hodgkin's lymphoma are the most common cancers observed in HIV-infected individuals.
  • Understanding cancer development in HIV is crucial for patient management and treatment strategies.

Purpose of the Study:

  • To review recent research advancements in understanding malignancy in HIV-infected individuals.
  • To provide an Australian perspective on the epidemiology and research of HIV-associated cancers.

Main Methods:

  • Literature review of recent studies on HIV-associated malignancies.
  • Analysis of research trends and findings from an Australian context.

Related Experiment Videos

Main Results:

  • Kaposi's sarcoma and non-Hodgkin's lymphoma continue to be the predominant cancers in HIV-positive populations.
  • Ongoing research is exploring the complex interplay between HIV, the immune system, and cancer development.
  • Advances in antiretroviral therapy have impacted the incidence and presentation of these malignancies.

Conclusions:

  • Despite advances, Kaposi's sarcoma and non-Hodgkin's lymphoma remain significant challenges in HIV care.
  • Continued research is essential to further elucidate mechanisms and improve outcomes for HIV-associated malignancies.
  • The Australian research landscape contributes valuable insights into managing these complex conditions.